Brief: Cancer Genetics - On January 4, Got Notice From Nasdaq Notifying Co That It No Longer Complies With Nasdaq Listing Rule
Jan 7 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS - ON JANUARY 4, GOT NOTICE FROM NASDAQ
NOTIFYING
CO THAT IT NO LONGER COMPLIES WITH NASDAQ LISTING RULE
* CANCER GENETICS - INTENDS TO SUBMIT TO NASDAQ A PLAN TO
REGAIN
COMPLIANCE WITH ANNUAL MEETING REQUIREMENT
Source text for Eikon: [ID:https://bit.ly/3s3lMoQ]
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration